CORONAVIRUS DISEASE 2019 (COVID-19) TREATMENT GUIDELINES

The guidance is based on proper case management aspects intended for clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not meant to replace clinical judgment or specialist consultation but rather to strengthen frontline clinical management and the public health response.

Renal diseases in the context of COVID-19

Kidney involvement is a frequent systemic complication in patients hospitalized with COVID-19, especially in critically ill patients. Renal manifestations range from mild proteinuria to severe acute kidney failure requiring renal replacement therapy (RRT).

Discharge and follow up in COVID-19

The discharging clinician should consider complications which might arise due to COVID-19 and react accordingly, the important things to note are;

• Post Hospital Discharge management,
• The post-COVID-19 syndrome and
• Post-COVID-19 pulmonary fibrosis

Psychiatry and mental illness in the context of COVID-19

Patients with psychiatric illness represent a high-risk population during the COVID-19 pandemic because they often have impaired judgment and difficulty adhering to infection-prevention measures, live in shared environments such as wards and rehabilitation homes, require close physical interactions with staff, possess higher rates of medical comorbidities, and may experience medication-related metabolic or respiratory vulnerabilities.

Newborn and child health services in the context of COVID-19

Children generally experience milder illness compared to adults; however, they play a major epidemiological role in transmission and a small proportion develop severe disease (e.g., pneumonia, hypoxia, inflammatory complications). Neonates are particularly vulnerable due to immature immunity and dependency on caregivers.